NEXGEL Reports Third Quarter Financial Performance
NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: NXGL) is gaining recognition as a prominent player in the healthcare and beauty industry, particularly with its innovative ultra-gentle, high-water-content hydrogel products. The company has recently shared its financial results for the third quarter of 2025, reflecting a steady performance for the period ended September 30, 2025.
Key Financial Highlights for the Third Quarter 2025
Steady Revenue and Margins
In the third quarter of 2025, NEXGEL reported net revenue of $2.93 million. This figure is reminiscent of the previous year, maintaining almost the same level compared to Q3 2024 ($2.94 million) and slight variations from Q2 2025 ($2.88 million). Such stability underscores the resilience of the Company against market fluctuations.
Gross Profit Insights
The Company achieved a gross profit of $1.24 million for the quarter, compared to $1.16 million in the same quarter last year. The gross profit margin stood at 42.4%, which reflects improvements over the previous year and a slight decrease from the preceding quarter.
Controlled Expenses
Operating expenses were reported at $1.96 million for Q3 2025, which is a slight increase from $1.94 million in Q3 2024. This increase primarily stemmed from higher compensation, benefits and consulting fees, while the Company effectively managed marketing and advertising costs.
Future Growth Potential
“While our revenue was flat year-over-year and sequentially, our Adjusted EBITDA loss continued to narrow,” remarked Adam Levy, CEO of NEXGEL. He highlighted the solid performance in contract manufacturing and consumer-branded products, affirming the market’s confidence in NEXGEL’s cutting-edge hydrogel technology. Growth from partnerships, including collaborations with major firms, has showcased NEXGEL's strategic advantage in expanding its customer base.
Financial Performance Overview
Cost Management and Profitability
The cost of revenues for Q3 2025 totaled $1.69 million, reflecting a decrease from $1.79 million in the same quarter last year. This improvement is attributed to reduced material costs and controlled operational spendings. NEXGEL's disciplined approach in managing costs aims to enhance its profitability as the company continues to scale its operations.
Cash Position and Financial Health
As of September 30, 2025, NEXGEL reported a cash balance of approximately $938 thousand. Moreover, with a restricted cash balance of $920 thousand linked to significant non-dilutive capital from partners, NEXGEL is well-positioned for future product launches and marketing strategies.
Strategic Initiatives and Product Innovation
Commitment to Innovation
NEXGEL is committed to advancing its product lines, particularly in beauty and skincare innovations, thereby enhancing its brand recognition in consumer markets. With the success of recent product launches set against a backdrop of economic challenges, this strategy reflects NEXGEL's adaptability and foresight.
Continued Growth in Contract Manufacturing
NEXGEL’s focus on contract manufacturing continues to yield positive results. Partnerships with reputable companies exemplify NEXGEL's capability to expand its operational reach while reinforcing the viability of its advanced hydrogel technology in diverse applications.
Conclusion: NEXGEL's Path Forward
As NEXGEL paves the way for future growth, the third quarter performance reflects not just resilience, but also an untapped potential for further success in both contract manufacturing and consumer brand sectors. With a strong fiscal foundation and a commitment to innovation, NEXGEL is poised to enhance its footprint in the healthcare and beauty industries.
Frequently Asked Questions
What is NEXGEL known for?
NEXGEL is recognized for its innovative healthcare and beauty products, particularly its ultra-gentle, high-water-content hydrogel offerings.
How did NEXGEL perform in the third quarter of 2025?
NEXGEL reported a net revenue of $2.93 million and a gross profit of $1.24 million, demonstrating stable performance compared to previous years.
What challenges did NEXGEL face recently?
The company faced flat revenue growth but successfully narrowed its Adjusted EBITDA loss through efficient cost management.
How does NEXGEL plan for future growth?
NEXGEL plans to enhance its product lines in the beauty sector and expand its contract manufacturing business through strategic partnerships.
What is the current cash position of NEXGEL?
As of September 30, 2025, NEXGEL had approximately $938 thousand in cash and a restricted cash balance of $920 thousand to support future operations.
